Latest Close
$3.16
News
AGEN
Agenus Inc. News
This news view pulls recent coverage and headlines tied to AGEN.
1y Change
-$0.63 (-16.62%)
Market Cap
$131,590,088.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
Business Wire • May 15, 2026
Read articleAgenus (AGEN) Q1 Earnings and Revenues Miss Estimates
Zacks • May 12, 2026
Read articleAgenus: Q1 Earnings Snapshot
Associated Press • May 11, 2026
Read articleRCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus
Zacks • May 11, 2026
Read articleAgenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development
Business Wire • May 11, 2026
Read articleVRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings
Zacks • May 8, 2026
Read article